To view this email as a web page, click here.

Targeted Therapy Proves Its Worth in Metastatic Kidney Cancer Patients

A new study found a biopsy of a single metastasis may be enough to help oncologists tailor a treatment that targets all of a patient's tumors.

Use of Metformin Disappoints in DLBCL, Follicular Lymphoma

A Mayo Clinic study tested metformin, believed to have anti-lymphoma activity, among patients with newly diagnosed diffuse large B-cell lymphoma or follicular lymphoma.

IN CASE YOU MISSED IT

Dr. Oratz on PARP Inhibitors to Treat Patients With Breast Cancer

Cancer Network spoke with Ruth Oratz, MD, a medical oncologist and breast cancer specialist at NYU Langone Perlmutter Cancer Center in New York City, about the use of poly (ADP-ribose) polymerase inhibitors for patients diagnosed with breast cancer.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.